Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Falasca

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Frontiers in Endocrinology|October 27, 2018
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1Silvano Paternoster, Marco Falasca
World Journal of Gastroenterology|August 26, 2014
Emerging role of the KRAS-PDK1 axis in pancreatic cancerRiccardo Ferro, Marco Falasca
Archives of Physiology and Biochemistry|December 21, 2006
Emerging roles of phosphatidylinositol 3-monophosphate as a dynamic lipid second messengerMarco Falasca, Tania Maffucci
Advances in Biological Regulation|January 31, 2013
Phosphoinositides signalling in cancer: focus on PI3K and PLCClaudio Raimondi, Marco Falasca
Cancers|November 28, 2015
Diet and Pancreatic Cancer PreventionIlaria Casari, Marco Falasca
Molecules (Basel, Switzerland)|November 17, 2020
Signalling Properties of Inositol PolyphosphatesTania Maffucci, Marco Falasca
Biomolecules|February 25, 2022
Targeting the Endocannabinoidome in Pancreatic CancerValerio Falasca, Marco Falasca
International Journal of Molecular Sciences|November 9, 2017
ABC Transporters in Cancer Stem Cells: Beyond ChemoresistanceRomana-Rea Begicevic, Marco Falasca
Expert Opinion on Investigational Drugs|April 13, 2012
Investigational ABC transporter inhibitorsMarco Falasca, Kenneth J Linton
Metabolites|January 20, 2016
Lysophosphatidylinositol Signalling and Metabolic DiseasesSyamsul A Arifin, Marco Falasca
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Frontiers in Endocrinology|October 27, 2018
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1Silvano Paternoster, Marco Falasca
World Journal of Gastroenterology|August 26, 2014
Emerging role of the KRAS-PDK1 axis in pancreatic cancerRiccardo Ferro, Marco Falasca
Archives of Physiology and Biochemistry|December 21, 2006
Emerging roles of phosphatidylinositol 3-monophosphate as a dynamic lipid second messengerMarco Falasca, Tania Maffucci
Advances in Biological Regulation|January 31, 2013
Phosphoinositides signalling in cancer: focus on PI3K and PLCClaudio Raimondi, Marco Falasca
Cancers|November 28, 2015
Diet and Pancreatic Cancer PreventionIlaria Casari, Marco Falasca
Molecules (Basel, Switzerland)|November 17, 2020
Signalling Properties of Inositol PolyphosphatesTania Maffucci, Marco Falasca
Biomolecules|February 25, 2022
Targeting the Endocannabinoidome in Pancreatic CancerValerio Falasca, Marco Falasca
International Journal of Molecular Sciences|November 9, 2017
ABC Transporters in Cancer Stem Cells: Beyond ChemoresistanceRomana-Rea Begicevic, Marco Falasca
Expert Opinion on Investigational Drugs|April 13, 2012
Investigational ABC transporter inhibitorsMarco Falasca, Kenneth J Linton
Metabolites|January 20, 2016
Lysophosphatidylinositol Signalling and Metabolic DiseasesSyamsul A Arifin, Marco Falasca
Pageof 15